Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 413

Trial Status

Completed12
Terminated1

Role Distribution

Other Roles13

Activity Timeline

Clinical Trials (13)

Showing 10 of 13 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (13)

Showing 13 of 13 trials

NCT00130468Phase 4StudyDirector

TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis

Osteoarthritis
Completed
NCT00237445Phase 4StudyDirector

Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days

Pneumonia
Terminated
NCT00283790Phase 4StudyDirector

Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo

Insomnia
Completed
NCT00296179Phase 4StudyDirector

Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro

Insomnia
Completed
NCT00296790Phase 4StudyDirector

Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)

Insomnia
Completed
NCT00547768Phase 4StudyDirector

Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.

Allergy
Completed
NCT00616694Phase 4StudyDirector

Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy

Osteoporosis
Completed
NCT00636870Phase 4StudyDirector

Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine

Allergic Rhinitis
Completed
NCT00637455Phase 4StudyDirector

Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel

Seasonal Allergic Rhinitis
Completed
NCT00637585Phase 4StudyDirector

Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine

Allergic Rhinitis
Completed
NCT00637611Phase 4StudyDirector

Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit

Seasonal Allergic Rhinitis
Completed
NCT00637884Phase 4StudyDirector

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms

Cat Induced Allergic Rhinitis
Completed
NCT00638118Phase 4StudyDirector

Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen

Allergic Rhinitis
Completed

All 13 trials loaded